Works matching AU Welsh, Paul


Results: 170
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11

    Routine measurement of cardiometabolic disease risk factors in primary care in England before, during, and after the COVID-19 pandemic: A population-based cohort study.

    Published in:
    PLoS Medicine, 2024, v. 21, n. 11, p. 1, doi. 10.1371/journal.pmed.1004485
    By:
    • Ho, Frederick K.;
    • Dale, Caroline;
    • Mizani, Mehrdad A.;
    • Bolton, Thomas;
    • Pearson, Ewan R.;
    • Valabhji, Jonathan;
    • Delles, Christian;
    • Welsh, Paul;
    • Nakada, Shinya;
    • Mackay, Daniel;
    • Pell, Jill P.;
    • Tomlinson, Chris;
    • Petersen, Steffen E.;
    • Bray, Benjamin;
    • Ashworth, Mark;
    • Rahimi, Kazem;
    • Mamas, Mamas;
    • Halcox, Julian;
    • Sudlow, Cathie;
    • Sofat, Reecha
    Publication type:
    Article
    12
    13
    14
    15
    16

    Clinical and metabolic features of the randomised controlled Diabetes Remission Clinical Trial (DiRECT) cohort.

    Published in:
    Diabetologia, 2018, v. 61, n. 3, p. 589, doi. 10.1007/s00125-017-4503-0
    By:
    • Taylor, Roy;
    • Leslie, Wilma S.;
    • Barnes, Alison C;
    • Brosnahan, Naomi;
    • Thom, George;
    • McCombie, Louise;
    • Sattar, Naveed;
    • Welsh, Paul;
    • Peters, Carl;
    • Zhyzhneuskaya, Sviatlana;
    • Hollingsworth, Kieren G.;
    • Al-Mrabeh, Ahmad;
    • Rodrigues, Angela M.;
    • Rehackova, Lucia;
    • Adamson, Ashley J.;
    • Sniehotta, Falko F.;
    • Mathers, John C.;
    • Ross, Hazel M.;
    • McIlvenna, Yvonne;
    • Kean, Sharon
    Publication type:
    Article
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30

    Weight loss‐induced increase in fasting ghrelin concentration is a predictor of weight regain: Evidence from the Diabetes Remission Clinical Trial (DiRECT).

    Published in:
    Diabetes, Obesity & Metabolism, 2021, v. 23, n. 3, p. 711, doi. 10.1111/dom.14274
    By:
    • Thom, George;
    • McIntosh, Alasdair;
    • Messow, Claudia‐Martina;
    • Leslie, Wilma S.;
    • Barnes, Alison C.;
    • Brosnahan, Naomi;
    • McCombie, Louise;
    • Malkova, Dalia;
    • Al‐Mrabeh, Ahmad;
    • Zhyzhneuskaya, Sviatlana;
    • Welsh, Paul;
    • Sattar, Naveed;
    • Taylor, Roy;
    • Lean, Michael E. J.
    Publication type:
    Article
    31
    32

    Genetic analysis of over half a million people characterises C-reactive protein loci.

    Published in:
    Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-29650-5
    By:
    • Said, Saredo;
    • Pazoki, Raha;
    • Karhunen, Ville;
    • Võsa, Urmo;
    • Ligthart, Symen;
    • Bodinier, Barbara;
    • Koskeridis, Fotios;
    • Welsh, Paul;
    • Alizadeh, Behrooz Z.;
    • Chasman, Daniel I.;
    • Sattar, Naveed;
    • Chadeau-Hyam, Marc;
    • Evangelou, Evangelos;
    • Jarvelin, Marjo-Riitta;
    • Elliott, Paul;
    • Tzoulaki, Ioanna;
    • Dehghan, Abbas
    Publication type:
    Article
    33
    34

    Subclinical Thyroid Dysfunction and Cognitive Decline in Old Age.

    Published in:
    PLoS ONE, 2013, v. 8, n. 3, p. 1, doi. 10.1371/journal.pone.0059199
    By:
    • Wijsman, Liselotte W.;
    • de Craen, Anton J. M.;
    • Trompet, Stella;
    • Gussekloo, Jacobijn;
    • Stott, David J.;
    • Rodondi, Nicolas;
    • Welsh, Paul;
    • Jukema, J. Wouter;
    • Westendorp, Rudi G. J.;
    • Mooijaart, Simon P.
    Publication type:
    Article
    35

    Soluble ST2 Associates with Diabetes but Not Established Cardiovascular Risk Factors: A New Inflammatory Pathway of Relevance to Diabetes?

    Published in:
    PLoS ONE, 2012, v. 7, n. 10, p. 1, doi. 10.1371/journal.pone.0047830
    By:
    • Miller, Ashley M.;
    • Purves, David;
    • McConnachie, Alex;
    • Asquith, Darren L.;
    • Batty, G. David;
    • Burns, Harry;
    • Cavanagh, Jonathan;
    • Ford, Ian;
    • McLean, Jennifer S.;
    • Packard, Chris J.;
    • Shiels, Paul G.;
    • Turner, Helen;
    • Velupillai, Yoga N.;
    • Deans, Kevin A.;
    • Welsh, Paul;
    • McInnes, Iain B.;
    • Sattar, Naveed
    Publication type:
    Article
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46

    Empagliflozin to prevent progressive adverse remodelling after myocardial infarction (EMPRESS‐MI): rationale and design.

    Published in:
    ESC Heart Failure, 2024, v. 11, n. 4, p. 2001, doi. 10.1002/ehf2.14830
    By:
    • Carberry, Jaclyn;
    • Petrie, Mark C.;
    • Lee, Matthew M.Y.;
    • Brooksbank, Katriona;
    • Campbell, Ross T.;
    • Good, Richard;
    • Jhund, Pardeep S.;
    • Kellman, Peter;
    • Lang, Ninian N.;
    • Mangion, Kenneth;
    • Mark, Patrick B.;
    • McConnachie, Alex;
    • McMurray, John J.V.;
    • Meyer, Barbara;
    • Orchard, Vanessa;
    • Shaukat, Aadil;
    • Watkins, Stuart;
    • Welsh, Paul;
    • Sattar, Naveed;
    • Berry, Colin
    Publication type:
    Article
    47
    48
    49
    50